| Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial R von Rotz, EM Schindowski, J Jungwirth, A Schuldt, NM Rieser, ... EClinicalMedicine 56, 2023 | 98 | 2023 |
| Pharmacokinetics and pharmacodynamics of γ‐hydroxybutyrate in healthy subjects ME Liechti, BB Quednow, E Liakoni, D Dornbierer, R von Rotz, ... British journal of clinical pharmacology 81 (5), 980-988, 2016 | 66 | 2016 |
| Gamma-hydroxybutyrate enhances mood and prosocial behavior without affecting plasma oxytocin and testosterone OG Bosch, C Eisenegger, J Gertsch, R von Rotz, D Dornbierer, ... Psychoneuroendocrinology 62, 1-10, 2015 | 44 | 2015 |
| Neural underpinnings of prosexual effects induced by gamma-hydroxybutyrate in healthy male humans OG Bosch, MM Havranek, A Baumberger, KH Preller, R von Rotz, ... European Neuropsychopharmacology 27 (4), 372-382, 2017 | 23 | 2017 |
| Gamma-hydroxybutyrate increases resting-state limbic perfusion and body and emotion awareness in humans OG Bosch, F Esposito, MM Havranek, D Dornbierer, R Von Rotz, ... Neuropsychopharmacology 42 (11), 2141-2151, 2017 | 22 | 2017 |
| Neuronal oscillations and synchronicity associated with gamma-hydroxybutyrate during resting-state in healthy male volunteers R von Rotz, M Kometer, D Dornbierer, J Gertsch, M Salomé Gachet, ... Psychopharmacology 234, 1957-1968, 2017 | 14 | 2017 |
| Gamma-hydroxybutyrate increases brain resting-state functional connectivity of the salience network and dorsal nexus in humans OG Bosch, F Esposito, D Dornbierer, MM Havranek, R Von Rotz, ... Neuroimage 173, 448-459, 2018 | 12 | 2018 |
| TMS-EEG and resting-state EEG applied to altered states of consciousness: oscillations, complexity, and phenomenology A Ort, JW Smallridge, S Sarasso, S Casarotto, R von Rotz, A Casanova, ... Iscience 26 (5), 2023 | 9 | 2023 |
| Prohedonic properties of gamma‐hydroxybutyrate are associated with changes in limbic resting‐state functional connectivity OG Bosch, F Esposito, D Dornbierer, R Von Rotz, R Kraehenmann, ... Human Psychopharmacology: Clinical and Experimental 33 (6), e2679, 2018 | 7 | 2018 |
| Effects of gamma-hydroxybutyrate on neurophysiological correlates of performance and conflict monitoring DA Dornbierer, M Kometer, R Von Rotz, E Studerus, J Gertsch, ... European Neuropsychopharmacology 29 (4), 539-548, 2019 | 6 | 2019 |
| Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial. eClinicalMedicine. 2023; 56: 101809 R von Rotz, EM Schindowski, J Jungwirth, A Schuldt, NM Rieser, ... Medline, 2022 | 5 | 2022 |
| Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N, N-dimethyltryptamine and harmine DA Dornbierer, L Marten, J Mueller, HD Aicher, MJ Mueller, M Boxler, ... Frontiers in Pharmacology 14, 1246892, 2023 | 2 | 2023 |
| Corrigendum to ‘Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial’ R von Rotz, EM Schindowski, J Jungwirth, A Schuldt, NM Rieser, ... EClinicalMedicine 56, 2023 | 2 | 2023 |
| Alpha oscillations underlie working memory abnormalities in the psychosis high-risk state A Ramyead, M Kometer, E Studerus, D Baumeler, R von Rotz, ... Biological psychology 126, 12-18, 2017 | 1 | 2017 |
| Potential therapeutic effects of an ayahuasca-inspired N, N-DMT and harmine formulation: a controlled trial in healthy subjects HD Aicher, MJ Mueller, DA Dornbierer, D Suay, C Elsner, I Wicki, ... Frontiers in Psychiatry 14, 1302559, 2024 | | 2024 |
| T97. Neural Underpinnings of the Hedonic Effects of Gamma-Hydroxybutyrate in Humans O Bosch, F Esposito, D Dornbierer, R von Rotz, P Staempfli, BB Quednow, ... Biological Psychiatry 83 (9), S166, 2018 | | 2018 |
| Neural Oscillations and Synchronicity Associated with Gamma-hydroxybutyrate During Resting-state R von Rotz Universität Zürich, 2016 | | 2016 |
